Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Darzalex (daratumumab)
pCPA File Number:
21169
Negotiation Status:
Under consideration for negotiation
Indication(s):
Multiple Myeloma
Sponsor/Manufacturer:
Janssen Inc.
CADTH Project Number:
pCODR 10189
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable